An Open Label, Multicenter Study, Evaluating the Imaging Characteristics of a Follow-up 18F-AV-1451 Scan in Subjects Who Have Had a Prior 18F-AV-1451 Scan

Trial Profile

An Open Label, Multicenter Study, Evaluating the Imaging Characteristics of a Follow-up 18F-AV-1451 Scan in Subjects Who Have Had a Prior 18F-AV-1451 Scan

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Feb 2017

At a glance

  • Drugs Flortaucipir F 18 (Primary)
  • Indications Alzheimer's disease
  • Focus Diagnostic use
  • Sponsors Avid Radiopharmaceuticals
  • Most Recent Events

    • 08 Feb 2017 Status changed from recruiting to completed.
    • 08 Apr 2015 Planned End Date changed from 1 Apr 2015 to 1 Nov 2015 as reported by ClinicalTrials.gov record.
    • 08 Apr 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Nov 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top